12, 2024 — Scientists have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

This accounts for 3% to 10% of all adult cases of non-Hodgkin's lymphoma. Mantle cell lymphoma is a subtype of B-cell non-Hodgkin’s lymphoma that primarily affects older adults. 1 While some ...

In studies, low blood cell levels commonly occurred in people taking Venclexta. The symptoms of this side effect depend on which types of blood cells have low levels. Anemia (low red blood cell ...

Tafasitamab (MOR-208, XmAb5574) is under development for the treatment of B cell malignancies including relapsed or refractory non-Hodgkin lymphoma, relapsed or refractory chronic lymphocytic leukemia ...

Bashar al-Assad, along with his family, fled Syria on December 8. Asma al-Assad, wife of deposed Syrian President Bashar al-Assad, is reportedly battling leukemia, an aggressive cancer of the bone ...

CCAR-066 (CBM.CD20 CAR-T) is under development for the treatment of chemotherapy resistant or refractory CD20+ leukemia and lymphoma including b-cell non-Hodgkin lymphoma, follicular lymphoma, mantle ...

Professor Kwang-Hyun Cho remarked, "The fact that cancer cells can be converted back to normal cells is an astonishing phenomenon. This study proves that such reversion can be systematically induced." ...

Investigators from Cedars-Sinai and the University of California, San Francisco (UCSF) have identified a new way to deliver instructions that tell stem cells to grow into specific bodily ...

Stage 4 diffuse large B-cell lymphoma (DLBCL) is a rapidly growing lymphoma affecting at least one other organ outside the lymphatic system. Cancer is the unusual growth and spread of cells within ...